Results 211 to 220 of about 99,950 (263)

An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors. [PDF]

Int J Mol Sci
Choucair K, Odabashian R, Reddy SN, Azmi AS, Saif MW.   +4 more
europepmc   +1 more source

The impact of radioligand therapy on prognosis in patients with lung neuroendocrine tumors. [PDF]

Front Endocrinol (Lausanne)
Jóźwik-Plebanek K, Saracyn M, Durma AD, Kołodziej M, Mądra W, Dziuk M, Janiak K, Balcerska Z, Gniadek-Olejniczak K, Kamiński G.   +9 more
europepmc   +1 more source

Comparing Response Evaluation Methods for PRRT in Neuroendocrine Tumors: Insights from an Exploratory Study. [PDF]

Cancers (Basel)
Guglielmo P, Carnaghi C, Bertuzzi AF, Laffi A, Damiani S, Riva UC, Olivieri M, Marenco M, Evangelista L.   +8 more
europepmc   +1 more source

A 40‐year‐old woman with a spinal mass

Brain Pathology, EarlyView.
Melissa Mejia‐Bautista, Margarita Loxas, Pouya Jamshidi, Drew Duckett, Jean‐Paul Wolinsky, Jared T. Ahrendsen   +5 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

Modern Pathology, 2021
The classification of adenohypophysial neoplasms as "pituitary neuroendocrine tumors" (PitNETs) was proposed in 2017 to reflect their characteristics as epithelial neuroendocrine neoplasms with a spectrum of clinical behaviors ranging from small indolent lesions to large, locally invasive, unresectable tumors.
Sylvia L. Asa, Ozgur Mete, Michael D. Cusimano, Ian E. McCutcheon, Arie Perry, Shozo Yamada, Hiroshi Nishioka, Olivera Casar-Borota, Silvia Uccella, Stefano La Rosa, Ashley B. Grossman, Shereen Ezzat, null International Pituitary Pathology, Sofia Asioli, Süheyla Uyar Bozkurt, Nil Comunoglu, Giulia Cossu, Peter Earls, Nuperi Gazioglu, Richard A. Hickman, Hidetoshi Ikeda, Emilija Manojlovic-Gacic, Mahmoud Messerer, Buge Öz, Sara Pakbaz, Federico Roncaroli, Wolfgang Saeger, John Turchini, Sema Yarman   +28 more
openaire   +2 more sources

NEUROENDOCRINE TUMORS

Journal of Computer Assisted Tomography, 2014
Several classification systems for neuroendocrine tumors (NETs) exist, which use variable terminology and criteria for grading and staging. This variability in terminology can cause confusion and difficulty in recognizing which tumors are, in fact, members of this heterogeneous group of malignancies.
SCHNABEL CATHERINE A, ZHANG YI, ERLANDER MARK G   +2 more
openaire   +7 more sources

Neuroendocrine Tumors

Gastroenterology Clinics of North America, 2016
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for other disorders initially. The diagnostic workup to characterize tumor behaviour and prognosis focuses on histologic, anatomic, and functional imaging assessments. Several therapeutic options exist
Basuroy, Ron, Srirajaskanthan, Raj, Ramage, John K   +2 more
openaire   +3 more sources

Neuroendocrine tumors of the diffuse neuroendocrine system

Current Opinion in Oncology, 2008
Neuroendocrine tumors (previously referred to as carcinoids) are ill-understood, enigmatic malignancies that, although slow-growing compared with adenocarcinomas, can behave aggressively. In 2004, they comprised 1.25% of all malignancies; their incidence is increasing by approximately 6% per year.
Björn I, Gustafsson, Mark, Kidd, Irvin M, Modlin   +2 more
openaire   +2 more sources